Karuna Therapeutics
Why Robinhood?
You can watch KRTX and buy or sell other stocks, ETFs, and their options commission-free!About KRTX
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.
KRTX Key Statistics
Stock Snapshot
Karuna Therapeutics(KRTX) stock is priced at $329.83, giving the company a market capitalization of 12.6B. It carries a P/E multiple of -28.13.
On 2026-04-02, Karuna Therapeutics(KRTX) stock opened at —, reached a high of —, and a low of —.
Karuna Therapeutics(KRTX) shares are trading with a volume of 0, against a daily average of 525.45K.
During the past year, Karuna Therapeutics(KRTX) stock moved between $158.38 at its lowest and $329.99 at its peak.
During the past year, Karuna Therapeutics(KRTX) stock moved between $158.38 at its lowest and $329.99 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.